Simon Voelkl

2.9k total citations · 1 hit paper
22 papers, 2.3k citations indexed

About

Simon Voelkl is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Simon Voelkl has authored 22 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 11 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Simon Voelkl's work include Immune Cell Function and Interaction (12 papers), CAR-T cell therapy research (10 papers) and T-cell and B-cell Immunology (7 papers). Simon Voelkl is often cited by papers focused on Immune Cell Function and Interaction (12 papers), CAR-T cell therapy research (10 papers) and T-cell and B-cell Immunology (7 papers). Simon Voelkl collaborates with scholars based in Germany, United States and Austria. Simon Voelkl's co-authors include Andréas Mackensen, Reinhard Andreesen, Karin Fischer, Leoni A. Kunz‐Schughart, Stefan W. Krause, Eva Gottfried, Kathrin Renner, Petra Hoffmann, Birgit Timischl and Norbert Meidenbauer and has published in prestigious journals such as Blood, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

Simon Voelkl

21 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibitory effect of tumor cell–derived lactic acid on human T cells

2007 1.5k citations Karin Fischer, Petra Hoffmann et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Voelkl Germany	10	1.2k	822	806	723	151	22	2.3k
Anthony T. Phan United States	13	1.7k 1.4×	780 0.9×	851 1.1×	674 0.9×	113 0.7×	21	2.6k
Jérôme Thiery France	24	930 0.8×	901 1.1×	729 0.9×	505 0.7×	114 0.8×	41	2.1k
Krithika N. Kodumudi United States	22	1.2k 1.0×	658 0.8×	1.1k 1.4×	413 0.6×	224 1.5×	49	2.3k
Susan M. Kaech United States	9	1.8k 1.5×	713 0.9×	779 1.0×	520 0.7×	99 0.7×	11	2.6k
Yasuto Akiyama Japan	27	708 0.6×	878 1.1×	937 1.2×	332 0.5×	270 1.8×	128	2.2k
Carsten Weishaupt Germany	21	863 0.7×	948 1.2×	1.3k 1.7×	327 0.5×	171 1.1×	61	2.6k
João T. Barata Portugal	36	1.3k 1.1×	1.7k 2.1×	1.0k 1.3×	389 0.5×	181 1.2×	81	3.7k
Bruce Freimark United States	17	785 0.6×	997 1.2×	458 0.6×	334 0.5×	240 1.6×	43	2.1k
Carmela De Santo United Kingdom	25	2.6k 2.2×	752 0.9×	1.3k 1.6×	351 0.5×	126 0.8×	40	3.6k
Nicole E. Scharping United States	18	2.2k 1.8×	1.0k 1.2×	1.4k 1.7×	754 1.0×	212 1.4×	26	3.4k

Countries citing papers authored by Simon Voelkl

Since Specialization

Citations

This map shows the geographic impact of Simon Voelkl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Voelkl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Voelkl more than expected).

Fields of papers citing papers by Simon Voelkl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Voelkl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Voelkl. The network helps show where Simon Voelkl may publish in the future.

Co-authorship network of co-authors of Simon Voelkl

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Voelkl. A scholar is included among the top collaborators of Simon Voelkl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Voelkl. Simon Voelkl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taubmann, Jule, Simon Voelkl, Laura Bucci, et al.. (2023). CD19-Targeted CAR-T Cells in Refractory Systemic Autoimmune Diseases: A Monocentric Experience from the First Fifteen Patients. Blood. 142(Supplement 1). 220–220. 9 indexed citations

Voelkl, Simon, Dimitrios Mougiakakos, Sebastian Boeltz, et al.. (2022). CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients. Blood. 140(Supplement 1). 4562–4563. 1 indexed citations

Voelkl, Simon, et al.. (2021). Hydrogen-Peroxide Synthesis and LDL-Uptake Controls Immunosuppressive Properties in Monocyte-Derived Dendritic Cells. Cancers. 13(3). 461–461. 7 indexed citations

Voelkl, Simon, et al.. (2021). Immune modulatory effects of Idelalisib in stromal cells of chronic lymphocytic leukemia. Leukemia & lymphoma. 62(11). 2679–2689. 3 indexed citations

Fuchs, Maximilian, Meik Kunz, Simon Voelkl, et al.. (2021). Protein kinase C-β-dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia. Stem Cells. 39(6). 819–830. 5 indexed citations

Bonin, Malte von, Michael Krämer, Christoph Röllig, et al.. (2020). Identification of Prognostic Immunophenotypes at First Diagnosis in Patients with Acute Myeloid Leukemia (AML) By a Standardized Multicolor Flow Cytometry (MFC) Panel Originally Designed to Detect Measurable Residual Disease (MRD) at Follow-up. Blood. 136(Supplement 1). 35–35. 1 indexed citations

Boettcher, Martin, Konstantinos Panagiotidis, Kristin Mentz, et al.. (2019). Microenvironmental Triggers Induce a Chemoresistant, Differentiated Subset of S100A8/A9high AML Cells Via the Jak/STAT3 Signaling Axis. Blood. 134(Supplement_1). 2714–2714.

Aigner, Michael, et al.. (2018). Human Double-Negative Regulatory T Cells Modulate Effector Functions of Conventional T Cells By Selectively Blocking mTOR Signaling. Blood. 132(Supplement 1). 2410–2410. 2 indexed citations

Gary, Regina, Simon Voelkl, Ralf Palmisano, et al.. (2011). Antigen-Specific Transfer of Functional Programmed Death Ligand 1 from Human APCs onto CD8+ T Cells via Trogocytosis. The Journal of Immunology. 188(2). 744–752. 30 indexed citations

10.

Voelkl, Simon, Regina Gary, & Andréas Mackensen. (2011). Characterization of the immunoregulatory function of human TCR‐αβ⁺ CD4⁻CD8⁻ double‐negative T cells. European Journal of Immunology. 41(3). 739–748. 84 indexed citations

11.

Voelkl, Simon, Regina Gary, & Andréas Mackensen. (2010). Characterization of the Immunoregulatory Function of Human TCRαβ+ CD4-CD8- Double-Negative T Cells. Blood. 116(21). 2776–2776. 22 indexed citations

12.

Voelkl, Simon, Tamson V. Moore, Michael Rehli, et al.. (2008). Characterization of MHC class-I restricted TCRαβ+ CD4− CD8− double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination. Cancer Immunology Immunotherapy. 58(5). 709–718. 32 indexed citations

13.

Moore, Tamson V., Gretchen E. Lyons, Natasha Brasic, et al.. (2008). Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition. Cancer Immunology Immunotherapy. 58(5). 719–728. 18 indexed citations

14.

Voelkl, Simon, Regina Gary, & Andréas Mackensen. (2008). Suppression of Allogeneic Immune Responses by Human TCRαβ+ CD4− CD8− Double-Negative T Cells.. Blood. 112(11). 1536–1536. 1 indexed citations

15.

Fischer, Karin, Petra Hoffmann, Simon Voelkl, et al.. (2007). Inhibitory effect of tumor cell–derived lactic acid on human T cells. Blood. 109(9). 3812–3819. 1465 indexed citations breakdown →

16.

Blank, Christian U., Juergen Kuball, Simon Voelkl, et al.. (2006). Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro. International Journal of Cancer. 119(2). 317–327. 251 indexed citations

17.

Fischer, Karin, Simon Voelkl, Jana Berger, et al.. (2006). Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. Blood. 108(13). 4094–4101. 136 indexed citations

18.

Fischer, Karin, Simon Voelkl, Jana Berger, et al.. (2006). Antigen Recognition Induces Phosphatidylserine Exposure on the Cell Surface of Human CD8+ T Cells.. Blood. 108(11). 1718–1718. 2 indexed citations

19.

Fischer, Karin, Simon Voelkl, Grzegorz K. Przybylski, et al.. (2005). Isolation and Characterization of Human Antigen-Specific TCRαβ+ CD4−CD8− Double Negative Regulatory T Cells.. Blood. 106(11). 3306–3306. 1 indexed citations

20.

Fischer, Karin, Simon Voelkl, Grzegorz K. Przybylski, et al.. (2004). Isolation and characterization of human antigen-specific TCRαβ+ CD4-CD8- double-negative regulatory T cells. Blood. 105(7). 2828–2835. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact